BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])

NCT07666490 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

644

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Beclometasone dipropionate, formoterol fumarate, and glycopyrronium bromide (100/6/12.5 µg per actuation)
DRUG: Foster® 200/6 pMDI (BDP/FF-200/6 µg)

Sponsor

Chiesi Farmaceutici S.p.A.